On May 23, 2017, in Callaghan v. Darlington Fabrics Co., a Rhode Island Superior Court issued a unique decision regarding employer obligations to medical marijuana users. The Judge who penned the decision began his analysis by quoting a 1967 lyric from The Beatles’ song “With A Little Help From My Friends”: “I get high with a little help from my friends.” In the 32-page opinion following this witty opening, the Court held that an employer’s refusal to hire an individual based on her medical marijuana use violated Rhode Island’s medical marijuana statute, and the employer’s conduct may have amounted to disability discrimination under the Rhode Island Civil Rights Act (“RICRA”). Continue Reading Refusal to Hire Medical Pot Users Just Got Riskier–At Least In Rhode Island
As of January 2017, 29 states have legalized medical marijuana. However, marijuana remains a Schedule l substance under the Controlled Substances Act. Substances in Schedule l are determined by the Food and Drug Administration (FDA) to have no medical use, and states that allow the use of marijuana for medical use violate federal law. Continue Reading Food and Drug Administration’s Regulation of Cannabis
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.
Mexico Casually One-Ups U.S. By Legalizing Medicinal Marijuana
(Forbes, 21 June 2017)
This week, Mexican President Enrique Peña Nieto informed the world that his country is taking its relationship with cannabis to the next level.
- PNC Bank is closing the Marijuana Policy Project’s account
(CNN Money: All News, 21 June 2017)
PNC Bank is closing its account with an influential marijuana legalization group, the Marijuana Policy Project.
- Medical cannabis legalization to appear on Oklahoma ballot in 2018
(Marijuana Business Daily: News, 21 June 2017)
Oklahoma will become the latest state to weigh in on the legalization of medical marijuana after the secretary of state’s office certified a ballot measure.
Something we missed that everyone needs to know? Give us a shout in the comments.
Attorney General Jeff Sessions is in the news for two reasons today: he’s testifying before the Senate Intelligence Committee on his possible links to Russia and a letter he wrote to Congress indicating his disapproval of the Rohrabacher-Farr Amendment has surfaced.
Last month we reported that Congress extended the Rohrabacher-Farr Amendment. No sooner was this extension passed, but Sessions wrote to Congress seeking its repeal. As many readers know, the Amendment prohibits the Justice Department from using federal funds to prevent states from implementing their own medical marijuana laws. It is, in essence, a victory for states’ rights, in the sense that they can decide whether to make medical marijuana legal, without fear of federal government interference.
Yesterday massroots.com, and today The Washington Post reported that in May, Sessions wrote to Congress stating that “it would be unwise for Congress to restrict the discretion of the Department [of Justice] to fund particular prosecutions, particularly in the midst of an historic drug epidemic and potentially long term uptick in violent crime.”
Of course, the “historic drug epidemic” to which Sessions refers has nothing to do with cannabis, but involves opiates, and, according to the Washington Post, a growing body of research shows that opiate overdoses decrease in states in which medical marijuana is legal. Sessions also wrote that “[t]he Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous traffickers who threaten American lives.” It is difficult to understand how Rohrabacher-Farr prevents the federal government from enforcing the Controlled Substances Act against those engaged in trafficking in drugs across state lines.
Sessions’ position is contrary to that of the President who expressed support for medical marijuana laws during his campaign. However, over the past several months there have been a number of mixed signals from the Administration regarding enforcement of the federal prohibition on the possession and sale of cannabis. These mixed signals have created tremendous uncertainty in all segments of the cannabis industry, but it is hard to believe that the Administration really intends to disrupt what has become a multi-billion dollar industry.
We could not let 4/20, National Weed Day, pass without a post, so here is an article from the Associated Press on the history and origins of the “holiday.”